Co-Diagnostics Inc (CODX)

Currency in USD
2.350
0.000(0.00%)
Closed·

CODX Earnings

Latest Release
Nov 13, 2025
EPS / Forecast
-0.16 / -0.16
Revenue / Forecast
100.00K / --
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
12/2025--/-0.13--/125.88K----Free Sign Up
09/2025-0.16/-0.16100K/--0%--Free Sign Up
06/2025-0.23/-0.66162.91K/200K+65.15%-18.55%Free Sign Up
03/2025-0.24/-0.3450.28K/400K+29.41%-87.43%Free Sign Up
12/2024-0.36/-0.33149.33K/375K-9.09%-60.18%Free Sign Up
09/2024-0.32/-0.33641.14K/375K+3.03%+70.97%Free Sign Up
06/2024-0.25/-0.342.66M/375K+26.47%+609.33%Free Sign Up
03/2024-0.31/-0.21500K/3.1M-47.62%-83.87%Free Sign Up
12/2023-1.2/-0.26.8M/2.5M-500%+172%Free Sign Up
09/2023-0.2/-0.292.5K/200K+31.03%-98.75%Free Sign Up

All numbers in USD

Co-Diagnostics Inc Earnings Call Summary for Q3/2025

  • Co-Diagnostics reported Q3 2025 EPS of -$0.16, meeting expectations, but revenue plummeted to $0.1M from $0.6M YoY, triggering a 6.11% stock drop in after-hours trading.
  • Operating expenses decreased to $7.1M from $10.6M in Q3 2024, narrowing net loss to $5.9M from $9.7M, demonstrating improved cost management despite revenue challenges.
  • CEO Dwight Egan announced strategic joint ventures in Saudi Arabia and India, emphasizing the company's entry into 'the next phase of growth from a position of strength.'
  • The company is pursuing multiple commercial launches in 2026, exploring financing options for international expansion, particularly in India and the Middle East.
  • With cash and equivalents at $11.4M, management faces pressure to reverse the concerning 89% twelve-month revenue decline as the stock has fallen 47% year-to-date.
Last Updated: 2025-11-13, 05:26 p/m
Read Full Transcript

FAQ

What Is Co-Diagnostics's Earnings Per Share (TTM)?

The Co-Diagnostics EPS (TTM) is -29.01.

When Is The Next Co-Diagnostics Earnings Date?

Co-Diagnostics will release its next earnings report on Mar 19, 2026.

What Is Co-Diagnostics’s Revenue Forecasts For Upcoming Quarters?

Co-Diagnostics’s revenue forecast is 163.53K.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.